Health Care · Hospital & Medical Service Plans

ALHC Alignment Healthcare, Inc. SEC Filings & Insider Trading Activity 2026

company
CIK 1832466120 filings
Russell 2000

ALHC at a glance

Alignment Healthcare, Inc. (ALHC, SEC CIK 1832466) filed its latest 10-K annual report on February 27, 2026, a 10-Q quarterly report on October 29, 2026, an 8-K current report on October 29, 2026 and Form 4 insider filings as recently as November 12, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended December 31, 2025 (FY2025), Alignment Healthcare, Inc. (ALHC) reported revenue of $3.9 billion (up 46.1% from FY2024) and a net loss of $724,000. Diluted EPS was $0.00.
  • As of September 30, 2026, 32 institutional investment managers tracked by SignalX reported holding Alignment Healthcare, Inc. (ALHC) shares worth $761.9 million in 13F-HR filings.
  • The most recent insider open-market sale reported on Form 4 was by KONOWIECKI JOSEPH S on November 10, 2026 of 4,930 shares at $7.20 per share.
  • In the last 90 days, ALHC insiders reported 0 open-market purchases ($0) and 7 open-market sales ($9.5M) on Form 4, a net sale of $9.5M.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2025
$3.9B
+46.1% vs prior year
Insiders · 90 days
0 buys · 7 sells
Net −$9.5M
13F holders
32 funds
$761.9M · −1 vs prior quarter
Latest 8-K
Oct 29, 2026
Item 2.02

AI 10-K Annual Report Analysis

Latest 10-K, fiscal year ended Dec 31, 2025

Full analysis →

Business Overview

  • Core business model: Consumer-centric Medicare Advantage plans focused on coordinated, proactive care for seniors using integrated clinical and technology platform
  • Emphasized this year: Expanded "Care Anywhere" in-house clinician-driven care model providing free, personalized at-home and virtual chronic condition management
  • Strategic shift: Greater investment in internal clinical staff (450 FTEs, 25% workforce) to reduce hospitalizations and improve outcomes via direct care delivery
  • Quantitative growth: Health Plan Membership reached 236,300 at 30% CAGR since inception with revenue 5-year CAGR of 36% through 2025
  • Noteworthy fact: Proprietary AVA platform integrates data from 200+ sources using AI for real-time, prescriptive care insights enhancing member and provider workflows

Risk Factors

  • Regulatory risk: potential loss/suspension of CMS Medicare Advantage contracts affecting revenue source
  • Macroeconomic threat: geographic concentration in few U.S. states limits expansion, increasing exposure to regional market downturns
  • Operational vulnerability: dependency on AVA AI platform for clinical initiatives poses risk of regulatory and operational setbacks
  • Competitive risk: competition for physician networks intensifies due to healthcare industry consolidation with better-resourced plans
  • Financial risk: accumulated deficit $1,009.0 million as of 12/31/2025 with net loss $1.0 million in 2025, $128.1 million in 2024

Management Discussion & Analysis

  • Revenue $3.949B, up 46.1% YoY; earned premiums $3.912B, +46.4% driven by 25% membership growth to 236,300 and higher PMPM rates
  • Operating income $14.8M vs loss $101.6M; operating margin 0.4% vs (3.7)% in prior year
  • Medical expenses segment largest, 87.6% of revenue vs 89.0%, MBR improved to 87.5% from 88.8%
  • Adjusted EBITDA $109.9M vs $1.3M; adjusted gross profit $494.8M, up 63.5%
  • Management outlook: focus on expanding membership (275,300 Health Plan Members as of Jan 1, 2026), new market entry, investing in AVA platform, strong CMS star ratings support financial incentives and sustainable growth

AI summary of the ALHC 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Sep 30, 2026

Management Discussion & Analysis

  • Revenue $1,358.3M, up 36.7% YoY from $993.7M, driven by earned premiums
  • Operating margin (0.2%) vs 0.8% YoY, medical benefits ratio 89.5% vs 87.2%
  • Earned premiums best-performing line, $1,348.3M, up 37.1% YoY
  • Cash, equivalents and short-term investments $743.0M vs $644.1M; operating cash flow $158.4M vs $190.3M
  • Medical cost trends higher than expected; 2027 California HMO rating fell to 3.5 stars, while liquidity expected sufficient for 12 months

Risk Factors

  • New risk: H3815, covering approximately 75% of membership, received 3.5 Stars for 2027
  • Financial risk: H3815’s lower rating reduces quality bonus payments beginning fiscal 2028
  • Regulatory risk: CMS Star methodology changes and litigation create uncertainty over future ratings
  • Operational risk: Higher cut points and weaker HOS and Part D measures drove H3815’s decline
  • Competitive risk: Low ratings may reduce enrollment and impede growth in Medicare Advantage markets

AI summary of the ALHC 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Oct 29, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Q3 2026 results released for quarter ended September 30, 2026
  • Full financial details available in Exhibit 99.1, the accompanying earnings press release

Item EX-99.1: Item EX-99.1

  • Q3 revenue $1.358B, up 36.7%, with membership up 31.2% to 301,200, confirming strong enrollment momentum
  • Medical benefits ratio worsened to 89.5%, up approximately 240 basis points, reflecting higher appeals, catastrophic and skilled-nursing costs
Filed Oct 8, 2026Full analysis →

Item 7.01: Regulation FD Disclosure

  • H3815, serving approximately 75% of members, fell to 3.5 Stars for 2027 from 4.0 Stars
  • Six other eligible plans retained at least 4.0 Stars, including three plans rated 4.5 Stars
Filed Jul 30, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Q2 2026 results covered quarter ended June 30, 2026
  • Press release issued July 30, 2026 and furnished as Exhibit 99.1

Item EX-99.1: Item EX-99.1

  • Q2 revenue $1,335.6M, up 31.6% year over year, reflecting continued Medicare Advantage scale
  • Medicare Advantage membership approximately 294,100, up 31.5%, supporting higher premium revenue

AI summaries of ALHC 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for ALHC

Don't miss the next ALHC filing

  • Alerts as it files. A push when ALHC files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut ALHC, by share count.
  • Ask anything. An AI agent that reads every ALHC filing and answers with sources.

ALHC alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
KONOWIECKI JOSEPH SSellNov 10, 2026$7.20
Kim HyongSellOct 6, 2026$8.30
KONOWIECKI JOSEPH SSellSep 17, 2026$8.61
KAO JOHN ESellSep 14, 2026$13.00
KAO JOHN ESellSep 11, 2026$12.68
Maroney Dawn ChristineSellSep 11, 2026$12.68
KAO JOHN ESellSep 10, 2026$12.96
Maroney Dawn ChristineSellAug 14, 2026$14.00

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2023FY2024FY2025
Profitability
Revenue-$2.7B$3.9B
Operating Income--$101.6M$14.8M
Net Income-$148.0M-$128.0M-$724K
Op. Margin--3.8%0.4%
Net Margin--4.7%-0.0%
Balance Sheet
Total Assets$591.9M$782.1M$1.1B
Equity-$99.9M$179.3M
ROE--128.2%-0.4%
Per Share
EPS$-0.79$-0.67$0.00
Cash Flow
Operating CF-$59.2M$34.8M$139.9M
CapEx-$41.4M$26.8M

Source: XBRL data in Alignment Healthcare, Inc. (ALHC)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q3 2026

Aggregate ALHC share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
ALHC shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q3 202632$761.9M
Q2 202633$2.57B
Q1 202633$1.64B
Q4 202527$1.61B
Q3 202528$1.33B
Q2 202526$990.8M
Q1 202524$760.9M
Q4 202421$461.4M
Position changes: Q2 2026 → Q3 2026
Top Buyers
Top Sellers
Closed Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 224 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

ALHC filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
4Nov 12, 2026--
8-KOct 29, 2026Analysis-
10-QOct 29, 2026Analysis
8-KOct 8, 2026Analysis-
4Oct 7, 2026--
4Sep 18, 2026--
4Sep 16, 2026--
4Sep 11, 2026--
4Sep 11, 2026--
4Aug 18, 2026--
SC 13GAug 13, 2026-
4Aug 10, 2026--
SC 13GJul 31, 2026-
8-KJul 30, 2026Analysis-
10-QJul 30, 2026Analysis
4Jul 16, 2026--
4Jul 14, 2026--
4Jul 2, 2026--
4Jul 1, 2026--
4Jun 26, 2026--
4Jun 18, 2026--
4Jun 15, 2026--
4Jun 15, 2026--
4Jun 12, 2026--
4Jun 12, 2026--

Related Health Care companies

All Health Care →

ALHC SEC filings: frequently asked questions

Are ALHC insiders buying or selling?

In the last 90 days, Alignment Healthcare, Inc. (ALHC) officers, directors and 10% owners reported no open-market purchases and 7 open-market sales worth $9.5 million by 4 insiders on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.

Which institutions hold ALHC stock?

As of September 30, 2026, the largest Alignment Healthcare, Inc. (ALHC) holders among the 13F filers tracked by SignalX were BlackRock ($206.1 million), Vanguard Portfolio Management LLC ($87.6 million), Vanguard Capital Management LLC ($68.5 million), State Street Corp ($64.5 million), Bank of America Corp ($48.6 million). 13F-HR reports are filed up to 45 days after each quarter ends.

What was ALHC's revenue in fiscal year 2025?

For the fiscal year ended December 31, 2025 (FY2025), Alignment Healthcare, Inc. (ALHC) reported revenue of $3.9 billion (up 46.1% from FY2024) and a net loss of $724,000. Diluted EPS was $0.00. The figures come from the XBRL data in the 10-K.

What are the main risks in ALHC's latest 10-K?

In the 10-K filed February 27, 2026, Alignment Healthcare, Inc. (ALHC) flagged: Regulatory risk: potential loss/suspension of CMS Medicare Advantage contracts affecting revenue source. Macroeconomic threat: geographic concentration in few U.S. states limits expansion, increasing exposure to regional market downturns. (AI summary of the Risk Factors section.)

What did ALHC report in its latest 8-K?

Alignment Healthcare, Inc. (ALHC) filed an 8-K on October 29, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q3 2026 results released for quarter ended September 30, 2026.

What are the latest ALHC SEC filings?

Alignment Healthcare, Inc. (ALHC) filed its latest 10-K annual report on February 27, 2026, a 10-Q quarterly report on October 29, 2026, an 8-K current report on October 29, 2026 and a Form 4 insider filing on November 12, 2026.

What is ALHC's SEC CIK number?

Alignment Healthcare, Inc. (ALHC)'s SEC Central Index Key (CIK) is 1832466. EDGAR lists every ALHC filing under that number.

Ask anything about ALHC

The research agent reads ALHC's filings, financials, insider trades and 13F holders, then answers with sources.